7:30am
|
REGISTRATION, BREAKFAST & NETWORKING
|
8:00am
|
WELCOME REMARKS
|
| , Chair, Alliance for Regenerative Medicine; President & CEO, Organogenesis Inc.
|
8:10am
|
FIRESIDE CHAT: THE FUTURE FOR THERAPEUTICS & TOOLS IN REGEN MED
|
| Speakers: |
|
Robert Preti, Ph.D. , President & Chief Scientific Officer, Progenitor Cell Therapy (PCT)
|
| Perry Karsen , CEO, Celgene Cellular Therapeutics; EVP & COO, Celgene Corporation
|
| Eric Roman, M.B.A. , General Manager, Research and Applied Markets, GE Healthcare Life Sciences
|
9:00am
|
ADVANCED THERAPY TREATMENTS FOR CARDIOVASCULAR DISEASE
|
| Speakers: |
| Edward Tenthoff , Managing Director & Senior Research Analyst, Piper Jaffray (moderator) |
| Andrew Pecora, M.D., Chief Visionary Officer, NeoStem; Co-Founder & Chief Medical Officer, PCT
|
| Marc Penn, M.D., Ph.D., Director of Research, Summa Cardiovascular Institute
|
| Thomas Povsic, M.D., Ph.D., Associate Professor of Medicine, Duke University Medical Center
|
| Andre Terzic, M.D., Ph.D., Michael S. & Mary Sue Shannon Director, Mayo Clinic Center for Regenerative Medicine
|
9:55am
|
MORNING BREAK
|
10:10am
|
GENE-MODIFIED THERAPIES: WILL THEY CHANGE OUR APPROACH TO TREATMENT?
|
| Speakers: |
| Joshua Schimmer, M.D., M.B.A. , Managing Director & Senior Research Analyst, Piper Jaffray (moderator) |
| Bruce Levine, Ph.D. , Barbara and Edward Netter Associate Professor in Cancer Gene Therapy, University of Pennsylvania
|
| Robert Ross, M.D. , Vice President, Clinical Development, bluebird bio
|
| Elizabeth Wolffe, Ph.D. , Vice President, Corporate Communications, Sangamo BioSciences
|
11:05am
|
COMMERCIALIZATION STRATEGIES & PATHWAYS TO MARKET
|
| Speakers: |
| Jason Kolbert, M.B.A. , Senior Managing Director & Head of Healthcare Research, Maxim Group (moderator) |
| Joyce Frey-Vasconcells, Ph.D. , Regulatory Expert, Frey-Vasconcells Consulting
|
| Tetsuo Heki , Senior Expert, Fujifilm Healthcare Business Development Office
|
| Gregory Russotti, Ph.D. , Vice President, Technical Operations, Celgene Cellular Therapeutics
|
| David Smith, M.B.A. , Head of Therapeutic Cell Solutions, Lonza
|
12:00pm
|
PLATED LUNCH & NETWORKING
|
12:30pm
|
LUNCH KEYNOTE PRESENTATION
|
1:00pm
|
COMPANY PRESENTATIONS
|